SE462139B - Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem - Google Patents
Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksemInfo
- Publication number
- SE462139B SE462139B SE8600501A SE8600501A SE462139B SE 462139 B SE462139 B SE 462139B SE 8600501 A SE8600501 A SE 8600501A SE 8600501 A SE8600501 A SE 8600501A SE 462139 B SE462139 B SE 462139B
- Authority
- SE
- Sweden
- Prior art keywords
- propylene glycol
- urea
- skin
- treatment
- nail
- Prior art date
Links
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 title claims abstract description 78
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title claims abstract description 24
- 239000004202 carbamide Substances 0.000 title claims abstract description 23
- 238000011282 treatment Methods 0.000 title claims abstract description 18
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 3
- 241000233866 Fungi Species 0.000 title description 5
- 235000013877 carbamide Nutrition 0.000 title 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 claims abstract description 11
- 208000008742 seborrheic dermatitis Diseases 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 208000010195 Onychomycosis Diseases 0.000 claims abstract description 6
- 208000017520 skin disease Diseases 0.000 claims abstract description 5
- 239000000654 additive Substances 0.000 claims abstract 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 23
- 235000014655 lactic acid Nutrition 0.000 claims description 11
- 239000004310 lactic acid Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 206010013786 Dry skin Diseases 0.000 claims description 4
- 230000037336 dry skin Effects 0.000 claims description 3
- 206010014190 Eczema asteatotic Diseases 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 239000012153 distilled water Substances 0.000 claims description 2
- 239000013543 active substance Substances 0.000 abstract description 7
- 239000002202 Polyethylene glycol Substances 0.000 abstract 2
- 229920001223 polyethylene glycol Polymers 0.000 abstract 2
- 208000007163 Dermatomycoses Diseases 0.000 abstract 1
- 206010040849 Skin fissures Diseases 0.000 abstract 1
- 208000020312 Thickened skin Diseases 0.000 abstract 1
- 201000003929 dermatomycosis Diseases 0.000 abstract 1
- 230000001329 hyperkeratotic effect Effects 0.000 abstract 1
- 201000005882 tinea unguium Diseases 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 12
- 210000004761 scalp Anatomy 0.000 description 8
- 239000002904 solvent Substances 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000000843 anti-fungal effect Effects 0.000 description 5
- 229940121375 antifungal agent Drugs 0.000 description 5
- 229940124091 Keratolytic Drugs 0.000 description 4
- 230000001530 keratinolytic effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000007712 Tinea Versicolor Diseases 0.000 description 3
- 206010056131 Tinea versicolour Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 201000000508 pityriasis versicolor Diseases 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- BHKKSKOHRFHHIN-MRVPVSSYSA-N 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one Chemical compound N[C@H](C)C1=C(CN2C(NC(C3=C2C=CN3)=O)=S)C=CC(=C1)Cl BHKKSKOHRFHHIN-MRVPVSSYSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 206010021198 ichthyosis Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- OJTDGPLHRSZIAV-UHFFFAOYSA-N propane-1,2-diol Chemical compound CC(O)CO.CC(O)CO OJTDGPLHRSZIAV-UHFFFAOYSA-N 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- ZJHHPAUQMCHPRB-UHFFFAOYSA-N urea urea Chemical compound NC(N)=O.NC(N)=O ZJHHPAUQMCHPRB-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Cosmetics (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8600501A SE462139B (sv) | 1986-02-04 | 1986-02-04 | Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem |
| EP87901161A EP0292495B1 (de) | 1986-02-04 | 1987-02-04 | Arzneimittel enthaltend propylenglykol und/oder polyäthylenglykol sowie harnstoff als hauptbestandteile |
| PCT/SE1987/000053 WO1987004617A1 (en) | 1986-02-04 | 1987-02-04 | Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof |
| AU70239/87A AU599086B2 (en) | 1986-02-04 | 1987-02-04 | Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof |
| DE8787901161T DE3773201D1 (de) | 1986-02-04 | 1987-02-04 | Arzneimittel enthaltend propylenglykol und/oder polyaethylenglykol sowie harnstoff als hauptbestandteile. |
| AT87901161T ATE67409T1 (de) | 1986-02-04 | 1987-02-04 | Arzneimittel enthaltend propylenglykol und/oder polyaethylenglykol sowie harnstoff als hauptbestandteile. |
| DK519387A DK165440C (da) | 1986-02-04 | 1987-10-02 | Farmaceutiske praeparater til topisk anvendelse indeholdende propylenglycol og/eller polyethylenglycol og urinstof som aktive hovedbestanddele |
| NO874150A NO174764C (no) | 1986-02-04 | 1987-10-02 | Fremgangsmåte for fremstilling av et preparat som er virksomt ved behandling av hyperkeratotiske og andre hudsykdommer |
| CA000573123A CA1330198C (en) | 1986-02-04 | 1988-07-27 | Pharmaceutical composition containing propylene glycol and urea as active main components and use thereof |
| US08/150,245 US5525635A (en) | 1986-02-04 | 1993-11-09 | Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8600501A SE462139B (sv) | 1986-02-04 | 1986-02-04 | Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8600501D0 SE8600501D0 (sv) | 1986-02-04 |
| SE8600501L SE8600501L (sv) | 1987-08-05 |
| SE462139B true SE462139B (sv) | 1990-05-14 |
Family
ID=20363358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8600501A SE462139B (sv) | 1986-02-04 | 1986-02-04 | Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0292495B1 (de) |
| AT (1) | ATE67409T1 (de) |
| AU (1) | AU599086B2 (de) |
| CA (1) | CA1330198C (de) |
| DE (1) | DE3773201D1 (de) |
| DK (1) | DK165440C (de) |
| NO (1) | NO174764C (de) |
| SE (1) | SE462139B (de) |
| WO (1) | WO1987004617A1 (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4889847A (en) * | 1986-11-03 | 1989-12-26 | Ortho Pharmaceutical Corporation | Prevention of glucocorticoid-induced skin atrophy |
| US5464610A (en) | 1992-10-15 | 1995-11-07 | Schering-Plough Healthcare Products, Inc. | Method for treating onychomycosis |
| GB9223034D0 (en) * | 1992-11-03 | 1992-12-16 | Surtech Int Ltd | Method and composition for prevention and/or treatment of dandruff and seborrhoeic dermatitis |
| DE4322395C1 (de) * | 1993-07-01 | 1994-07-28 | Kuehnl Petzoldt Christa Dr Med | Duschlotion zur Behandlung und Pflege trockener Haut |
| US5391367A (en) * | 1993-07-28 | 1995-02-21 | Pfizer Inc. | Antifungal nail solution |
| US5916545A (en) * | 1993-07-28 | 1999-06-29 | Pfizer Inc. | Antifungal nail solution |
| SE9403541L (sv) * | 1994-10-14 | 1996-04-15 | Sven Moberg | Antimikrobiell komposition |
| GB2302808A (en) * | 1995-07-04 | 1997-02-05 | Surtech Int Ltd | Propylene glycol with low potency corticosteroids for topical treatment of the scalp |
| US6623724B2 (en) | 1996-09-18 | 2003-09-23 | Applied Genetics Incorporated Dermatics | Dermatological compositions and methods |
| EP0957903B1 (de) * | 1996-09-18 | 2005-08-10 | Applied Genetics Incorporated Dermatics | Norbornen- und norbornandiolen zur behandlung von pigmentierungsstörungen, neurodegenerativen erkrankungen oder proliferativen hauterkrankungen |
| AU754420B2 (en) * | 1997-11-25 | 2002-11-14 | Leo Pharma A/S | Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases |
| DE69932922T2 (de) * | 1998-02-13 | 2007-05-03 | Buck, Carol J. | Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen |
| AUPQ002999A0 (en) | 1999-04-29 | 1999-05-20 | Soltec Research Pty Ltd | Non-aqueous shampoo composition |
| US6858215B2 (en) | 2002-06-14 | 2005-02-22 | Carol J. Buck | Compositions and methods for softening, thinning and removing hyperkeratotic tissue |
| US6835385B2 (en) | 2002-06-14 | 2004-12-28 | Carol J. Buck | Compositions and methods for softening, thinning and removing hyperkeratotic tissue |
| CA2492976C (en) * | 2002-09-05 | 2011-11-01 | Galderma Research & Development, S.N.C. | Solution for ungual and peri-ungual application |
| FR2844197B1 (fr) * | 2002-09-05 | 2006-06-23 | Galderma Res & Dev | Solution pour application ungueale et peri-ungeale |
| WO2005115368A1 (en) * | 2004-05-31 | 2005-12-08 | Al Tayeb Fayez Hussien | Carrier composition for topical formulations |
| EP1683511A1 (de) * | 2005-01-13 | 2006-07-26 | Laboratoires S.V.R. | Harnstoof enthaltende Schuppen-regulierende zusammensetzung und ihre dermatologische verwendung |
| EP1965757B1 (de) | 2005-11-14 | 2016-11-23 | L'Oréal | Kosmetische verwendung eines hydroxyalkyl-harnstoffs als mittel zur behandlung desquamativer leiden der kopfhaut sowie zusammensetzung und verfahren zur kosmetischen anwendung |
| WO2008046796A2 (en) * | 2006-10-20 | 2008-04-24 | Symrise Gmbh & Co. Kg | Use of c10-c14-alkane-1,2-diols in the preparation of a composition for the prophylaxis and/or treatment of dermatophyte infections |
| ES2336995B1 (es) | 2008-10-13 | 2011-02-09 | Lipotec, S.A. | Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas. |
| US20100292333A1 (en) * | 2009-05-15 | 2010-11-18 | bioCEPTA Corporation | Compositions suitable for the topical treatment of fungal infections of the skin and nails |
| US20140205639A1 (en) * | 2013-01-22 | 2014-07-24 | bioCEPTA Corporation | Compositions suitable for the topical treatment of fungal infections of the skin and nails |
| EP2316436A1 (de) | 2009-10-30 | 2011-05-04 | Johnson & Johnson GmbH | Band, insbesondere Klebeband zur Behandlung von Hauterkrankungen mit mindestens einem Film, insbesondere einem löslichen Film, mit mindestens einem Enzym |
| EP2316438A1 (de) | 2009-10-30 | 2011-05-04 | Johnson & Johnson GmbH | Band, insbesondere Klebeband zur Behandlung von Hauterkrankungen mit mindestens einem Hyperkeratosehemmer und/oder mindestens einem keratinolytischem Wirkstoff |
| NL2003786C2 (en) * | 2009-11-11 | 2010-07-30 | Medner B V | COMPOSITION FOR TOPICAL APPLICATION, USES THEREOF, APPLICATOR DEVICE AND KIT OF PARTS. |
| WO2012110430A1 (en) | 2011-02-10 | 2012-08-23 | Moberg Derma Ab | Novel composition for topical use on a nail |
| EA024483B1 (ru) * | 2011-05-12 | 2016-09-30 | Аукзилиум Кура Инноватио | Местная композиция для лечения гиперкератотической кожи |
| WO2014140507A1 (en) | 2013-03-15 | 2014-09-18 | Moberg Pharma Ab | Pharmaceutical composition for the treatment of fungal infections |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3395236A (en) * | 1961-09-28 | 1968-07-30 | Cleveland J. White | Composition comprising oleic acid, polyethylene glycol, and gelating for treating nail infections |
| SE325667B (de) * | 1968-03-06 | 1970-07-06 | Medisan Ab | |
| DE2608221B1 (de) * | 1976-02-28 | 1977-07-21 | Beiersdorf Ag | Kosmetisches mittel zur glaettung der haut |
| US4239781A (en) * | 1979-05-03 | 1980-12-16 | Roy Edwards | Method for treating skin ailments |
| DE3210138A1 (de) * | 1982-03-19 | 1983-09-22 | Röhm Pharma GmbH, 6100 Darmstadt | Antimykotische, therapeutische zubereitungen auf creme- und salbenbasis |
| AU570998B2 (en) | 1983-09-07 | 1988-03-31 | Takeda Chemical Industries Ltd. | Topical steroid compositions for acne |
-
1986
- 1986-02-04 SE SE8600501A patent/SE462139B/sv not_active IP Right Cessation
-
1987
- 1987-02-04 WO PCT/SE1987/000053 patent/WO1987004617A1/en not_active Ceased
- 1987-02-04 AU AU70239/87A patent/AU599086B2/en not_active Ceased
- 1987-02-04 AT AT87901161T patent/ATE67409T1/de not_active IP Right Cessation
- 1987-02-04 DE DE8787901161T patent/DE3773201D1/de not_active Expired - Lifetime
- 1987-02-04 EP EP87901161A patent/EP0292495B1/de not_active Expired - Lifetime
- 1987-10-02 DK DK519387A patent/DK165440C/da not_active IP Right Cessation
- 1987-10-02 NO NO874150A patent/NO174764C/no not_active IP Right Cessation
-
1988
- 1988-07-27 CA CA000573123A patent/CA1330198C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU599086B2 (en) | 1990-07-12 |
| AU7023987A (en) | 1987-08-25 |
| EP0292495A1 (de) | 1988-11-30 |
| EP0292495B1 (de) | 1991-09-18 |
| DK165440C (da) | 1993-04-13 |
| SE8600501D0 (sv) | 1986-02-04 |
| WO1987004617A1 (en) | 1987-08-13 |
| NO874150L (no) | 1987-12-02 |
| ATE67409T1 (de) | 1991-10-15 |
| DK165440B (da) | 1992-11-30 |
| NO174764C (no) | 1994-07-06 |
| CA1330198C (en) | 1994-06-14 |
| DE3773201D1 (de) | 1991-10-24 |
| DK519387A (da) | 1987-10-02 |
| SE8600501L (sv) | 1987-08-05 |
| NO174764B (no) | 1994-03-28 |
| DK519387D0 (da) | 1987-10-02 |
| NO874150D0 (no) | 1987-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE462139B (sv) | Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem | |
| US4839164A (en) | Trehalose containing cosmetic composition and method of using it | |
| Kyle et al. | Topical therapy for fungal infections | |
| US6821508B2 (en) | Composition and method for topical nail treatment | |
| ES2301189T3 (es) | Agentes de limpieza antimicrobianos. | |
| Huang et al. | A novel foam vehicle for delivery of topical corticosteroids | |
| US8318214B2 (en) | Method for treating onychoschizia | |
| US10721937B1 (en) | Preservative systems and compositions and methods incorporating same | |
| BR112020001850B1 (pt) | Mistura antimicrobiana, composição, processo de tratamento cosmético e processo para conservar uma composição | |
| JP3049593B2 (ja) | 育毛・養毛剤 | |
| AU2017320876B2 (en) | Methods and compositions for treating cutaneous fungal infections | |
| JP6346962B2 (ja) | 皮膚を水和させるための美容組成物 | |
| US5652256A (en) | Topical composition for fungal treatment | |
| ES2280629T3 (es) | Dapsone topico para el tratamiento del acne. | |
| JP2958662B2 (ja) | 発毛・養毛促進剤 | |
| ES2259210T3 (es) | Uso de una composicion y procedimiento cosmetico para reducir e impedir el escozor en la piel. | |
| JPH1129482A (ja) | 医薬組成物 | |
| US20090192125A1 (en) | Local anti-infective agent for treatment of nail fungal infections | |
| US20060280703A1 (en) | Antimycotic nail varnish | |
| JP2006501223A (ja) | 真菌感染を治療する方法 | |
| US11554108B2 (en) | Methods and compositions for treating cutaneous fungal infections | |
| ES2881312T3 (es) | Mezcla antimicrobiana que contiene 4-(3-etoxi-4-hidroxifenil)butan-2-ona, y composición cosmética que la contiene | |
| JP3678415B2 (ja) | 皮膚外用剤 | |
| Murdan | Focal drug delivery to the nail | |
| Braun-Falco et al. | Topical therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8600501-4 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |